Corticobasal Degeneration Latest Advances

Understanding Tau pathology: Insights from animal models.

Journal: Zoological research

Published: September 29, 2025

CNS-Tau Specific Antibodies Illuminate Disease Signatures Across Tauopathies.

Journal: bioRxiv : the preprint server for biology

Published: September 26, 2025

Diagnosis of Alzheimer's disease using biological markers in corticobasal syndrome

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 29, 2025

Molecular Insights into the Effect of S262 Phosphorylation on the Binding of Tau256-267 to Microtubule and Its Self-Aggregation.

Journal: The journal of physical chemistry. B

Published: August 19, 2025

Progressive Supranuclear Palsy and Corticobasal Syndrome.

Journal: Continuum (Minneapolis, Minn.)

Published: August 01, 2025

Accumulation of LRRK2-associated phospho-Rab12 degenerative lysosomes in tauopathies.

Journal: bioRxiv : the preprint server for biology

Published: July 15, 2025

Corticobasal degeneration preceded by cognitive impairment and apathy: An autopsy case report.

Journal: PCN reports : psychiatry and clinical neurosciences

Published: June 11, 2025

In search of the optimal MRI marker for progressive supranuclear palsy: a large, single-center, retrospective study on the effect of phenotype, diagnostic certainty and disease duration.

Journal: Journal of neurology

Published: June 11, 2025

Pilot Study of [11C]HY-2-15: A Mixed Alpha-Synuclein and Tau PET Radiotracer.

Journal: Cells

Published: May 31, 2025

Complement dysregulation in human tauopathies.

Journal: Brain pathology (Zurich, Switzerland)

Published: May 03, 2025

Imaging of Proteinopathies in the Brains of Parkinsonian Disorders.

Journal: Cells

Published: May 02, 2025

A Biomarker-Based Classification of Corticobasal Syndrome.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: May 01, 2025

Filters

Understanding Tau pathology: Insights from animal models.

Understanding Tau pathology: Insights from animal models.

CNS-Tau Specific Antibodies Illuminate Disease Signatures Across Tauopathies.

CNS-Tau Specific Antibodies Illuminate Disease Signatures Across Tauopathies.

Diagnosis of Alzheimer's disease using biological markers in corticobasal syndrome

Diagnosis of Alzheimer's disease using biological markers in corticobasal syndrome

Molecular Insights into the Effect of S262 Phosphorylation on the Binding of Tau256-267 to Microtubule and Its Self-Aggregation.

Molecular Insights into the Effect of S262 Phosphorylation on the Binding of Tau256-267 to Microtubule and Its Self-Aggregation.

Progressive Supranuclear Palsy and Corticobasal Syndrome.

Progressive Supranuclear Palsy and Corticobasal Syndrome.

Accumulation of LRRK2-associated phospho-Rab12 degenerative lysosomes in tauopathies.

Accumulation of LRRK2-associated phospho-Rab12 degenerative lysosomes in tauopathies.

Corticobasal degeneration preceded by cognitive impairment and apathy: An autopsy case report.

Corticobasal degeneration preceded by cognitive impairment and apathy: An autopsy case report.

In search of the optimal MRI marker for progressive supranuclear palsy: a large, single-center, retrospective study on the effect of phenotype, diagnostic certainty and disease duration.

In search of the optimal MRI marker for progressive supranuclear palsy: a large, single-center, retrospective study on the effect of phenotype, diagnostic certainty and disease duration.

Pilot Study of [11C]HY-2-15: A Mixed Alpha-Synuclein and Tau PET Radiotracer.

Pilot Study of [11C]HY-2-15: A Mixed Alpha-Synuclein and Tau PET Radiotracer.

Complement dysregulation in human tauopathies.

Complement dysregulation in human tauopathies.

Imaging of Proteinopathies in the Brains of Parkinsonian Disorders.

Imaging of Proteinopathies in the Brains of Parkinsonian Disorders.

A Biomarker-Based Classification of Corticobasal Syndrome.

A Biomarker-Based Classification of Corticobasal Syndrome.